Both using receptor antagonists or chemical inhibitors to reduce the expression of pro-inflammatory cytokines such as IL-1, IL-17, IL-18, IL-23, IFN-, TGF-, CXCL16, NLRP3, and by in vitro injection or chemical intervention to increase the expression of anti-inflammatory cytokines, including IL-10, IL-13, IL-15, IL-22, IL-24, IL-33c, CCR2, CXCL10, G-CSF, EGF, VEGF, can help to reduce liver inflammation and promote liver damage repair
Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression
Health 247 ZenaroE.PiacentinoG.ConstantinG
Nulla at venenatis eros
Contributes to the prevention of premature signs of aging